HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liqun Huang Selected Research

Sulindac (Copal)

7/2021Phospho-Sulindac (OXT-328) Inhibits Dry Eye Disease in Rabbits: A Dose-, Formulation- and Structure-Dependent Effect.
2/2019The ocular pharmacokinetics and biodistribution of phospho-sulindac (OXT-328) formulated in nanoparticles: Enhanced and targeted tissue drug delivery.
5/2015Phospho-NSAIDs have enhanced efficacy in mice lacking plasma carboxylesterase: implications for their clinical pharmacology.
9/2014The in vitro metabolism of phospho-sulindac amide, a novel potential anticancer agent.
9/2013Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics.
8/2013Aerosol administration of phospho-sulindac inhibits lung tumorigenesis.
6/2013Topically applied phospho-sulindac hydrogel is efficacious and safe in the treatment of experimental arthritis in rats.
11/2012Phospho-sulindac (OXT-328) inhibits the growth of human lung cancer xenografts in mice: enhanced efficacy and mitochondria targeting by its formulation in solid lipid nanoparticles.
10/2012Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer.
9/2012Regioselective oxidation of phospho-NSAIDs by human cytochrome P450 and flavin monooxygenase isoforms: implications for their pharmacokinetic properties and safety.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liqun Huang Research Topics

Disease

25Neoplasms (Cancer)
12/2020 - 01/2009
6Dry Eye Syndromes (Dry Eye Syndrome)
01/2022 - 01/2018
6Colonic Neoplasms (Colon Cancer)
09/2013 - 10/2010
5Pancreatic Neoplasms (Pancreatic Cancer)
05/2015 - 01/2009
5Lung Neoplasms (Lung Cancer)
12/2014 - 11/2012
5Breast Neoplasms (Breast Cancer)
02/2014 - 09/2011
3Inflammation (Inflammations)
01/2021 - 03/2010
3Prostatic Neoplasms (Prostate Cancer)
12/2020 - 01/2019
3Carcinogenesis
12/2014 - 07/2011
2Triple Negative Breast Neoplasms
10/2018 - 02/2014
2Carcinoma (Carcinomatosis)
10/2016 - 01/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2014 - 08/2013
2Arthritis (Polyarthritis)
06/2013 - 09/2012
1Lung Injury
04/2021
1Hypothermia
04/2021
1Type 2 Diabetes Mellitus (MODY)
01/2020
1Hyperthermia
12/2019
1Male Infertility (Male Sterility)
01/2019
1Asthma (Bronchial Asthma)
03/2018
1Alopecia (Baldness)
11/2017
1Urinary Bladder Neoplasms (Bladder Cancer)
10/2016
1Hydronephrosis
10/2016
1Pyuria
01/2016
1Experimental Arthritis
06/2013
1Osteitis
06/2013
1Cardiotoxicity
04/2013
1Melanoma (Melanoma, Malignant)
10/2012
1Skin Neoplasms (Skin Cancer)
10/2012
1Thinness
12/2011
1Osteoarthritis
12/2011

Drug/Important Bio-Agent (IBA)

15Sulindac (Copal)FDA LinkGeneric
07/2021 - 10/2010
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2014 - 01/2009
5Pharmaceutical PreparationsIBA
01/2020 - 03/2010
5Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
05/2015 - 10/2010
52-(4-isobutylphenyl)propionic acid 4-(diethoxyphosphoryloxy)butyl esterIBA
12/2014 - 06/2011
4OXT-328IBA
01/2022 - 10/2012
4Anti-Inflammatory Agents (Anti-Inflammatories)IBA
09/2014 - 03/2010
3GoldIBA
12/2020 - 01/2018
3Ibuprofen (Motrin)FDA LinkGeneric
12/2014 - 06/2011
3Eflornithine (Ornidyl)FDA Link
07/2011 - 10/2010
2Concanavalin AIBA
01/2020 - 01/2018
2Estrogen ReceptorsIBA
01/2014 - 01/2012
2Antineoplastic Agents (Antineoplastics)IBA
01/2014 - 12/2011
2Drug CombinationsIBA
09/2013 - 07/2011
2HydrogelsIBA
06/2013 - 10/2012
2F2-Isoprostanes (F2 Isoprostanes)IBA
11/2012 - 09/2011
2EstersIBA
09/2011 - 06/2011
2nitroxy-butyl-acetylsalicylic acidIBA
03/2010 - 01/2009
2Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2010 - 01/2009
2Proteins (Proteins, Gene)FDA Link
06/2008 - 09/2007
1CytokinesIBA
12/2021
1RNA (Ribonucleic Acid)IBA
04/2021
1ChemokinesIBA
01/2021
1ferric oxide (iron oxide)IBA
01/2020
1ZincIBA
01/2020
1Amino AcidsFDA Link
01/2020
1Therapeutic UsesIBA
12/2019
1arseniteIBA
01/2019
1OvalbuminIBA
03/2018
1Sulfur DioxideIBA
03/2018
1cucurbit(7)urilIBA
01/2018
1Alkaline CeramidaseIBA
11/2017
1CeramidesIBA
11/2017
1phospho-ibuprofen amideIBA
12/2014
1AmidesIBA
09/2014
1Acetylcysteine (Siran)FDA LinkGeneric
01/2014
1MicellesIBA
09/2013
1CurcuminIBA
09/2013
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2013
1ErbB Receptors (EGF Receptor)IBA
08/2013
1AerosolsIBA
08/2013
1Interleukin-6 (Interleukin 6)IBA
06/2013
1Freund's AdjuvantIBA
06/2013
1Poloxamer (Poloxamer 407)IBA
06/2013
1Interleukin-10 (Interleukin 10)IBA
06/2013
1Indomethacin (Indometacin)FDA LinkGeneric
04/2013
1Dinoprostone (PGE2)FDA Link
04/2013
1Cimetidine (Biomet)FDA LinkGeneric
01/2013
1Valproic Acid (Depakote)FDA LinkGeneric
01/2013
1Lipid NanoparticlesIBA
11/2012
1Liposomes (Liposome)IBA
01/2012
1Progesterone Receptors (Progesterone Receptor)IBA
01/2012
1ThioredoxinsIBA
01/2012
1Messenger RNA (mRNA)IBA
12/2011
1sclerotinIBA
12/2011
1Thioredoxin-Disulfide ReductaseIBA
09/2011
1NitrogenIBA
09/2011
1Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2011
1Fluorouracil (Carac)FDA LinkGeneric
09/2011
1Vincristine (Oncovin)FDA LinkGeneric
09/2011

Therapy/Procedure

6Therapeutics
12/2020 - 12/2011
4Photothermal Therapy
12/2020 - 01/2018
2Intravenous Injections
01/2019 - 10/2018
2Drug Therapy (Chemotherapy)
01/2018 - 11/2010
2Nephroureterectomy
10/2016 - 01/2016
1Precision Medicine
12/2020
1Lasers (Laser)
12/2020
1Topical Administration
02/2019
1Ophthalmic Administration
02/2019
1Oral Administration
06/2013